Erino Angelo Rendina

Dr. Erino Angelo Rendina


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2018 in Multidisciplinary Respiratory Medicine
Verified
Journal Article
Open access
PDF file
ASAlessandra Siciliani
Alessandra Siciliani
ERErino Angelo Rendina
Erino Angelo Rendina
MIMohsen Ibrahim
Mohsen Ibrahim
Tracheal surgery requires a highly specialized team of anesthesiologists, thoracic surgeons, and operative support staff. It remain a formidable challenge for surgeons due to the criticality connected to anatomical considerations, intraoperative airway management, technical complexity of reconstruction, and the potential postoperative morbidity and mortality. This article focuses on the main technical aspects and literature data regarding laryngotracheal and tracheal resection and reconstruction. Particular attention will be paied to anastomotic and non-anastomotic complications. Results from literature confirm that, when feasible, laryngotracheal and tracheal resection and reconstruction is the treatment of choice in cases of benign stricture and malign neoplasm. Careful patient selection, operative planning, and execution are required for optimal results.

16 April 2020 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
BMBeatrice Trabalza Marinucci
Beatrice Trabalza Marinucci
GMGiulio Maurizi
Giulio Maurizi
CVCamilla Vanni
Camilla Vanni
GCGIUSEPPE CARDILLO
GIUSEPPE CARDILLO
CPCamilla Poggi
Camilla Poggi
ERErino Angelo Rendina
Erino Angelo Rendina
OBJECTIVES: Few experiences comparing paediatric and adult patients treated for pulmonary sequestration (PS) have been reported. Surgical treatment is considered the best choice, but the time of surgery is still controversial. We present our experience in this setting, comparing characteristics, histological results and outcome of paediatric and adult patients undergoing PS resection. METHODS: Between 1998 and 2017, a total of 74 patients underwent lobectomy or sublobar resection for PS. Sixty patients were children (group A: ≤16 years old) and 14 were adults (group B: >16 years old). Preoperative diagnosis was radiological. PS was intralobar (42 cases) and extralobar (32 cases). The operation was a muscle-sparing lateral thoracotomy or video-assisted thoracoscopic surgery. Preoperative characteristics, histological results and short-/long-term results of the 2 groups were retrospectively analysed and compared. RESULTS: Thirty-seven percent of the patients in group A presented with respiratory symptoms and 79% in group B (P = 0.44). Most symptomatic patients were treated with a lobectomy. In group A, 2 patients (3%) had a malignant transformation of the lesion. Patients with a prenatal diagnosis treated after the age of 1 year became more symptomatic than those operated on before the age of 1 year (57% vs 23%; P = 0.08). No differences were found in postoperative complications. Long-term stable remission of respiratory symptoms was obtained in 91% of patients in group A and 100% in group B. Adulthood (P = 0.03) and the association with congenital cystic adenomatoid malformation (P = 0.03) were negative prognostic factors for the development of respiratory symptoms. CONCLUSIONS: Surgical treatment of PS is safe and feasible. Despite the small number of patients included, study results indicated that an early operation during childhood may prevent the subsequent development of respiratory symptoms. Surgical treatment is also recommended to prevent the rare transformation into malignancy.

9 November 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CVClaudia De Vitis
Claudia De Vitis
GCGiacomo Corleone
Giacomo Corleone
VSValentina Salvati
Valentina Salvati
FAFrancesca Ascenzi
Francesca Ascenzi
MPMatteo Pallocca
Matteo Pallocca
RMRita Mancini
Rita Mancini
Background: According to the cancer stem cells (CSCs) hypothesis, a population of cancer cells with stem cell properties is responsible for tumor propagation, drug resistance, and disease recurrence. Study of the mechanisms responsible for lung CSCs propagation is expected to provide better understanding of cancer biology and new opportunities for therapy. Methods: The Lung Adenocarcinoma (LUAD) NCI-H460 cell line was grown either as 2D or as 3D cultures. Transcriptomic and genome-wide chromatin accessibility studies of 2D vs. 3D cultures were carried out using RNA-sequencing and Assay for Transposase Accessible Chromatin with high-throughput sequencing (ATAC-seq), respectively. Reverse transcription polymerase chain reaction (RT-PCR) was also carried out on RNA extracted from primary cultures derived from malignant pleural effusions to validate RNA-seq results. Results: RNA-seq and ATAC-seq data disentangled transcriptional and genome accessibility variability of 3D vs. 2D cultures in NCI-H460 cells. The examination of genomic landscape of genes upregulated in 3D vs. 2D cultures led to the identification of 2D cultures led to the identification of Beta-1,4-galactosyltranferase 1 (B4GALT1) as the top candidate. B4GALT1 as the top candidate. B4GALT1 was validated as a stemness factor, since its silencing caused strong inhibition of 3D spheroid formation. Conclusion: Combined transcriptomic and chromatin accessibility study of 3D vs. 2D LUAD cultures led to the identification of B4GALT1 as a new factor involved in the propagation and maintenance of LUAD CSCs.

1 February 2001 in Transplantation Proceedings
Verified
Journal Article
Closed access
CRCarlo Della Rocca
Carlo Della Rocca
CCC Coccia
C Coccia
MCM.G Costa
M.G Costa
LPL Pompei
L Pompei
PMP Di Marco
P Di Marco
RCR Cortesini
R Cortesini

1 January 2016
Verified
Journal Article
Open access
PDF file
CMCecilia Menna
Cecilia Menna
MIMohsen Ibrahim
Mohsen Ibrahim
CAClaudio Andreetti
Claudio Andreetti
ACAnna Maria Ciccone
Anna Maria Ciccone
ADAntonio D’andrilli
Antonio D’andrilli
ERErino Angelo Rendina
Erino Angelo Rendina
Long term compensatory sweating results after sympathectomy for palmar and axillary hyperhidrosis

30 September 2022 in Cancers
Verified
Journal Article
Open access
PDF file
CMCecilia Menna
Cecilia Menna
ERErino Angelo Rendina
Erino Angelo Rendina
ADAntonio D'Andrilli
Antonio D'Andrilli
Reconstruction of the pulmonary artery (PA) associated with lobectomy for the radical resection of lung cancer has been progressively gaining diffusion in lung cancer surgery as a safe and effective therapeutic option that may allow radical resection when lobectomy is not technically feasible, avoiding pneumonectomy. There are some controversial aspects concerning the intraoperative and perioperative management of a sleeve resection with PA reconstruction that may influence the outcome. In the present article, the authors have analyzed some of the main technical and oncological aspects to take stock of what they have learned from their lung-sparing operations experience over time. PA reconstruction may require prosthetic materials including different options with variable cost. A main concern in vascular reconstructive procedures is avoiding tension on the anastomosis. When PA reconstruction is required, appropriate anticoagulation management is crucial. Results from the main literature data confirm the reliability of lobectomy associated with PA reconstruction in terms of perioperative morbidity and long-term survival. Sleeve lobectomy and PA reconstruction can be performed safely and effectively even after induction therapy.